
Foundation Medicine to Provide Tumor Molecular Profiling to Veterans with Cancer
Foundation Medicine was awarded its second consecutive, five-year contract by the U.S. Department of Veterans…
Foundation Medicine was awarded its second consecutive, five-year contract by the U.S. Department of Veterans…
Scale Biosciences (Scale Bio), a leader in innovative and scalable single cell analysis solutions, today…
Lexogen, a leader in RNA sequencing solutions, announces the launch of two groundbreaking products designed…
Small RNAs are short non-coding RNA molecules that regulate gene expression at the post-transcriptional level.…
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today…
Eclipse Bioinnovations has announced the launch of its eSENSE dsRNA™ assay…
Foundation Medicine, a leader in comprehensive genomic profiling, is excited to announce a strategic collaboration…
Investment in Oxford Nanopore, innovators of a transformational new generation of sensing technology that today…
The new ExomeReveal™ test by Ambry Genetics combines traditional exome sequencing with RNA analysis, which…
Lexogen, a leader in RNA sequencing technologies, is thrilled to announce the launch of the RiboCop…